Prevalence and Risk Factors of Moderate-to-Severe Hepatic Steatosis in Human Immunodeficiency Virus Infection: The Copenhagen Co-morbidity Liver Study
- 16 May 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 222 (8), 1353-1362
- https://doi.org/10.1093/infdis/jiaa246
Abstract
Background People with human immunodeficiency virus (PWH) may be at risk of nonalcoholic fatty liver disease. We compared the prevalence of moderate-to-severe hepatic steatosis (M-HS) in PWH with human immunodeficiency virus (HIV)-uninfected controls and determined risk factors for M-HS in PWH. Methods The Copenhagen Co-Morbidity in HIV Infection study included 453 participants, and the Copenhagen General Population Study included 765 participants. None had prior or current viral hepatitis or excessive alcohol intake. Moderate-to-severe hepatic steatosis was assessed by unenhanced computed tomography liver scan defined by liver attenuation ≤48 Hounsfield units. Adjusted odds ratios (aORs) were computed by adjusted logistic regression. Results The prevalence of M-HS was lower in PWH compared with uninfected controls (8.6% vs 14.2%, P < .01). In multivariable analyses, HIV (aOR, 0.44; P < .01), female sex (aOR, 0.08; P = .03), physical activity level (aOR, 0.09; very active vs inactive; P < .01), and alcohol (aOR, 0.89 per unit/week; P = .02) were protective factors, whereas body mass index (BMI) (aOR, 1.58 per 1 kg/m2; P < .01), alanine transaminase (ALT) (aOR, 1.76 per 10 U/L; P < .01), and exposure to integrase inhibitors (aOR, 1.28 per year; P = .02) were associated with higher odds of M-HS. Conclusions Moderate-to-severe hepatic steatosis is less common in PWH compared with demographically comparable uninfected controls. Besides BMI and ALT, integrase inhibitor exposure was associated with higher prevalence of steatosis in PWH.Keywords
Funding Information
- Simonsen Foundation
- Novo Nordisk Foundation
- Lundbeck Foundation
- Rigshospitalet Research Council
- Danish National Research Foundation (126)
This publication has 39 references indexed in Scilit:
- The Effect of Elevated Body Mass Index on Ischemic Heart Disease Risk: Causal Estimates from a Mendelian Randomisation ApproachPLoS Medicine, 2012
- Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studiesBMJ, 2010
- Hepatic Steatosis (Fatty Liver Disease) in Asymptomatic Adults Identified by Unenhanced Low-Dose CTAmerican Journal of Roentgenology, 2010
- Prevalence and Factors Associated With Liver Test Abnormalities Among Human Immunodeficiency Virus–Infected PersonsClinical Gastroenterology and Hepatology, 2010
- Nonalcoholic Fatty Liver Disease Among HIV-Infected PersonsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapyJournal of Hepatology, 2008
- Nonalcoholic Fatty Liver Disease in HIV‐Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and PredictorsClinical Infectious Diseases, 2008
- Nonalcoholic fatty liver disease and mitochondrial dysfunctionWorld Journal of Gastroenterology, 2008
- Comparison of CT Methods for Determining the Fat Content of the LiverAmerican Journal of Roentgenology, 2007
- Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes FederationDiabetic Medicine, 2006